This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Protein phosphorylation is an important posttranslational modification involved in regulating the functional activity of cellular proteins. Regulated phosphorylation is initiated by the enzymatic activity of specific protein kinases. The kinases Akt and GSK3? contribute to cellular signaling pathways that regulate cellular decisions such as growth, survival, and death. Specifically, Akt promotes survival and growth, whereas GSK3? promotes cell death. One substrate of both of these kinases is the transcription factor LSF (Late SV40 Factor). LSF, like these kinases, has been shown to be involved in signaling pathways that regulate cell survival, growth, and death. In order to better understand how LSF activity is regulated, we have undertaken studies to locate the sites of Akt and GSK3? phosphorylation on LSF. Our approach to locating LSF phosphorylation utilizes in vitro phosphorylation of recombinant purified LSF together with mass spectrometry analysis. In vitro phosphorylated LSF is subjected to enzymatic digestion to produce peptides that are of appropriate size for MS analysis. Digests are then analyzed by matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry to identify peptides that have a mass increase (80-Da increments) consistent with phosphorylation. For those peptides that contain more potential phosphorylation sites (Ser, Thr) than the number of added phosphate groups, tandem mass spectrometry (MS/MS) analysis is used to locate the precise position of phosphorylation. Early in this study, we used MALDI MS to identify two LSF peptides by which were phosphorylated following incubation with Akt. The low abundance of these peptides precluded location of the phosphorylation site(s) by direct MS/MS analysis. In order to enrich for phosphopeptides, we utilized immobilized metal ion chromatography (IMAC) with methyl esterification prior to MS analysis. However, no phosphopeptides were identified from this preparation by either MALDI MS or negative-ion nanoESI precursor ion scanning experiments. Another approach was incorporation of 32P into the vitro kinase reaction and isolation of labeled peptides from 2D TLC peptide maps. Phosphorylated peptides were extracted from the TLC plate and stored until the 32P signal was undetectable. Subsequent MALDI MS results from replicate experiments indicated that abundance of the peptides was too low to be detected. We have followed the in vitro phosphorylation of a synthetic peptide that corresponds to the sequence of LSF fromSer289 to Ser302 (with the addition of a C-terminal Cys, and phosphoSer at position 296, S289PSPGFNpSSHSSFS302C). This peptide was phosphorylated in vitro with GSK-3 followed by reduction, alkylation with iodoacetamide and C18 reversed-phase purification. NanoESI MSMS analysis identified phosphorylation at Ser291. In addition, we found evidence for phosphorylation at Ser289, however, the mass of the potential phosphorylated b2(1+) ion overlapped with the mass of the y2(1+) ion. Subsequent alkylation of the peptide with iodoacetic acid rather than iodoacetamide shifted the y2 ion mass, thus allowing the confirmation of phosphorylation at Ser289. This data is being utilized to generate Ser to Ala mutations in LSF for determination of the functional significance of this phosphorylation. In addition, improvements in the approaches we have available for determinations of low-level phosphorylation are leading to improved MS results.

Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
Biotechnology Resource Grants (P41)
Project #
5P41RR010888-10
Application #
7369210
Study Section
Special Emphasis Panel (ZRG1-BECM (03))
Project Start
2006-07-01
Project End
2007-06-30
Budget Start
2006-07-01
Budget End
2007-06-30
Support Year
10
Fiscal Year
2006
Total Cost
$1,335
Indirect Cost
Name
Boston University
Department
Biochemistry
Type
Schools of Medicine
DUNS #
604483045
City
Boston
State
MA
Country
United States
Zip Code
02118
Wang, Yun Hwa Walter; Meyer, Rosana D; Bondzie, Philip A et al. (2016) IGPR-1 Is Required for Endothelial Cell-Cell Adhesion and Barrier Function. J Mol Biol 428:5019-5033
Pu, Yi; Ridgeway, Mark E; Glaskin, Rebecca S et al. (2016) Separation and Identification of Isomeric Glycans by Selected Accumulation-Trapped Ion Mobility Spectrometry-Electron Activated Dissociation Tandem Mass Spectrometry. Anal Chem 88:3440-3
Hu, Han; Khatri, Kshitij; Klein, Joshua et al. (2016) A review of methods for interpretation of glycopeptide tandem mass spectral data. Glycoconj J 33:285-96
Ji, Yuhuan; Bachschmid, Markus M; Costello, Catherine E et al. (2016) S- to N-Palmitoyl Transfer During Proteomic Sample Preparation. J Am Soc Mass Spectrom 27:677-85
Rahimi, Nader; Costello, Catherine E (2015) Emerging roles of post-translational modifications in signal transduction and angiogenesis. Proteomics 15:300-9
Théberge, Roger; Dikler, Sergei; Heckendorf, Christian et al. (2015) MALDI-ISD Mass Spectrometry Analysis of Hemoglobin Variants: a Top-Down Approach to the Characterization of Hemoglobinopathies. J Am Soc Mass Spectrom 26:1299-310
Yu, Xiang; Sargaeva, Nadezda P; Thompson, Christopher J et al. (2015) In-Source Decay Characterization of Isoaspartate and β-Peptides. Int J Mass Spectrom 390:101-109
Walsh, Erica M; Niu, MengMeng; Bergholz, Johann et al. (2015) Nutlin-3 down-regulates retinoblastoma protein expression and inhibits muscle cell differentiation. Biochem Biophys Res Commun 461:293-9
Steinhorn, Benjamin S; Loscalzo, Joseph; Michel, Thomas (2015) Nitroglycerin and Nitric Oxide--A Rondo of Themes in Cardiovascular Therapeutics. N Engl J Med 373:277-80
Srinivasan, Srimathi; Chitalia, Vipul; Meyer, Rosana D et al. (2015) Hypoxia-induced expression of phosducin-like 3 regulates expression of VEGFR-2 and promotes angiogenesis. Angiogenesis 18:449-62

Showing the most recent 10 out of 250 publications